Avapro and Pregnancy

Avapro is antihypertension medicine as it erases vessel-narrowing effect of angiotensin, decreases concentration of aldosterone in plasma and secretion of catecholamines. And although it causes side effects very seldom, it is contraindicated in case of pregnancy: the pregnancy category C by FDA (I trimester); the pregnancy category D by FDA (II and III trimesters). Category C witnesses that the med holds potential risks to animal fetuses, while D means that it is dangerous to unborn human babies.
When being pregnant, the female’s organism is influenced by a lot of changes. All systems and organs go through double loading, including liver, kidneys, and heart. It concerns alvus in a special way, as there happen the most active processes of growth, division and development of a new organism.
When taking Avapro, a future mother may feel improvement of health, while for a fetus the in-take of the medication may have deplorable consequences. This medicine is ineligible for all period of being pregnant. However, the non-safest is the first trimester, namely the first three months of the prenatal development. It is exactly at this period that the maximal development of the fetus takes place and growth of all vitally important systems and organs. Avapro can change blood circulation in the alvus, metabolism between mother and fetus, impact on the speed of growth of cells, and all those factors that can lead to the development of birth defects to this or that degree, to bleeding or loss of life.
Specialists recommend to treat taking Avapro very cautiously not only for future mother, but father as well. One should stop taking medication long before planning to become pregnant.
For the time of treatment, one should stop breast-feeding, as it is contraindicative, and it is not know exactly whether irbersartan is excreted into breast milk.